SCLC is the most predominant histology among pulmonary NECs [6], and it is characterized by ubiquitous inactivating mutations in both TP53 and RB transcriptional corepressor 1 (RB1) [42–46]. The gene discussed is TP53; the disease is small cell lung carcinoma.